PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
19.75%
Similar revenue growth to CRWV's 23.55%. Walter Schloss would investigate if similar growth reflects similar quality.
17.92%
Similar cost growth to CRWV's 19.16%. Walter Schloss would investigate if industry cost pressures are temporary.
20.01%
Similar gross profit growth to CRWV's 25.15%. Walter Schloss would investigate industry dynamics.
0.21%
Margin expansion below 50% of CRWV's 1.30%. Michael Burry would check for structural issues.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
21.51%
Operating expenses growth 1.1-1.25x CRWV's 17.97%. Bill Ackman would demand justification.
20.82%
Total costs growth 1.1-1.25x CRWV's 18.28%. Bill Ackman would demand justification.
No Data
No Data available this quarter, please select a different quarter.
42.91%
D&A growth above 1.5x CRWV's 26.15%. Michael Burry would check for excessive investment.
20.39%
EBITDA growth 50-75% of CRWV's 33.05%. Martin Whitman would scrutinize operations.
0.95%
EBITDA margin growth below 50% of CRWV's 7.69%. Michael Burry would check for structural issues.
17.93%
Operating income growth below 50% of CRWV's 169.93%. Michael Burry would check for structural issues.
-1.52%
Operating margin decline while CRWV shows 156.60% growth. Joel Greenblatt would examine position.
9.24%
Other expenses growth while CRWV reduces costs. John Neff would investigate differences.
17.54%
Pre-tax income growth exceeding 1.5x CRWV's 9.63%. David Dodd would verify competitive advantages.
-1.85%
Pre-tax margin decline while CRWV shows 26.86% growth. Joel Greenblatt would examine position.
17.60%
Tax expense growth above 1.5x CRWV's 3.78%. Michael Burry would check for concerning trends.
17.51%
Net income growth exceeding 1.5x CRWV's 7.67%. David Dodd would verify competitive advantages.
-1.88%
Net margin decline while CRWV shows 25.27% growth. Joel Greenblatt would examine position.
25.00%
Similar EPS growth to CRWV's 23.08%. Walter Schloss would investigate industry trends.
25.00%
Similar diluted EPS growth to CRWV's 23.08%. Walter Schloss would investigate industry trends.
-7.81%
Share count reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.
-7.81%
Diluted share reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.